Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Tanreqing oral liquid for common cold with wind-heat syndrome
ChiCTR1900022951Phase 3Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2019
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tanreqing in nasopharyngitis (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Duration of all symptoms. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
tanreqing
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on ChiCTR1900022951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022951.